BP11123 PLGA 65:35, Lauryl Ester Terminated, IV: 0.35–0.45 dl/g, Mw: 38–53 kDa

PLGA 65:35, Lauryl Ester Terminated, IV: 0.35–0.45 dl/g, Mw: 38–53 kDa Description

PLGA 65:35, Lauryl Ester Terminated, IV: 0.35–0.45 dl/g, Mw: 38–53 kDa is a copolymer comprised of lactic and glycolic acid in a 65:35 ratio. The lauryl ester termination modifies the polymer's surface energy and interaction profiles. Its defined intrinsic viscosity and molecular weight distribution support predictable degradation and mechanical integrity, making it a suitable candidate for applications in controlled release systems and tissue engineering research.

PLGA 65:35, Lauryl Ester Terminated, IV: 0.35–0.45 dl/g, Mw: 38–53 kDa Applications

Biomedical Research and Drug Delivery
   - Used as a matrix component in microencapsulation systems to achieve controlled drug release by leveraging the predictable degradation profile.
   - Applied as a carrier in injectable formulations to enhance the localised release of therapeutics through its tunable degradation kinetics.

Tissue Engineering
   - Employed as a scaffold in regenerative medicine to support cell growth whilst gradually resorbing, thereby balancing tissue integration and scaffold support through its controlled molecular weight.
   - Utilised as a substrate in 3D printed structures to achieve spatially defined degradation, facilitating tissue remodelling in engineered constructs.

PLGA 65:35, Lauryl Ester Terminated, IV: 0.35–0.45 dl/g, Mw: 38–53 kDa Packing

The product is packaged in moisture-resistant, light-protective containers to minimise exposure to environmental variables. Each package is sealed to prevent contamination and is stored under controlled ambient conditions. Packaging includes a desiccant to maintain dryness and can be customised for bulk orders with additional protective measures based on customer specifications.

Additional Information

PLGA copolymers play a significant role in the field of biomaterials due to their biodegradability and tunable degradation properties. Understanding the interplay between molecular weight, intrinsic viscosity, and chain-end modifications is essential for optimising performance in various biomedical applications. Researchers often rely on these parameters to tailor material properties for specific therapeutic delivery or tissue regeneration tasks.

The science behind ester terminations, such as the lauryl modification here, provides insight into how minor chemical adjustments can significantly influence polymer behaviour. This detailed approach supports improved design strategies for advanced biocompatible materials in both academic and industrial settings.

Regulatory Note: This material is intended for industrial and research applications. It is the customer's responsibility to ensure compliance with all relevant safety and regulatory standards in their intended use.